Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Home-based exoskeleton training to help people with spinal cord injury walk

Official title: Clinical Investigation on the Safety and Performance of the ABLE Daily to Assist People With Spinal Cord Injury in Performing Ambulatory Functions in Home and Community Settings

Run by ABLE Human Motion S.L. · NCT07062575 · Data updated 2026-11-12

This trial tests whether the ABLE Daily exoskeleton can safely help adults with spinal cord injury stand, walk, and navigate stairs at home and in the community.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment10 (estimated)
SponsorABLE Human Motion S.L.
Industry-sponsored
Locations1 site (Hengstdal, Ubbergen)
StatusRecruiting
StartedJune 19, 2025
Main results expectedOctober 30, 2026
Study endsOctober 30, 2026
Registry record updatedJune 2, 2026
Trial IDNCT07062575 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (≥18) with chronic spinal cord injury (≥6 months) from T1 to L5, with WISCI 0–9, BMI <30, and able to train at least 3 days/week with a companion.

Probably not a fit

Individuals with higher fracture risk, recent fragility fractures, or unable to meet training or companion requirements may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Participants with chronic spinal cord injury will undergo a 3-week on-site training period (9 sessions) followed by 12 weeks of home use with the ABLE Daily exoskeleton. The device is a bilateral wearable exoskeleton that assists hip and knee movement to enable standing, walking, ramp navigation, and sitting. Pre- and post-assessments will measure safety and performance, and training will involve a companion or buddy learning to assist during home use. Eligibility requires adults 18–<em>any</em> with specific SCI levels and functional criteria, plus a willingness and ability to train regularly with a support person.

Why it matters

Potential benefit: If successful, participants may gain safer and more capable ambulatory function in daily activities.

How similar studies have gone: Prior studies in other exoskeletons have shown safety and feasibility in gait training, but home-use data remain limited for ABLE Daily.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* At least 18 years old
* Chronic SCI (\>6 months)
* Injury at levels T1 to L5 (AIS A to D)
* Walking Index for Spinal Cord Injury (WISCI) score 0 until 9
* Height between 150-200 cm
* Weight less than 100 kg
* Capable of giving informed consent on their own
* Able to train (at least) 3 days/week
* Able to have at least 1 companion / buddy who can attend a minimum of two of the training sessions, besides the final assessment, and who will learn how to assist them at home and in the community (ideally two companions)
* Proficiency in walking with the ABLE Exoskeleton
* At least 8 weeks with minimal use (less than 5 sessions) of wearable robotic exoskeletons for gait assistance at the start of the study.

Exclusion Criteria:

* High risk of fractures due to osteoporosis, a dual energy X-ray absorptiometry (DEXA)-scan at the hip, distal femur, and proximal tibia BMD score
* Fragility fractures of the lower limbs in the last 2 years
* Deterioration \>3 in the International Standards for Neurological Classification of SCI (ISNCSCI) score in the last 4 weeks
* Spinal instability, like spondylolisthesis
* Disorders of the arms and hands that make walking with crutches impossible
* Modified Ashworth Scale (MAS) \>3 in lower limbs
* Cardiovascular health issues which prevent the participant from training
* Instability to tolerate 10 minutes of standing without clinical symptoms of orthostatic hypotension
* Psychological, cognitive issues, or any other condition that does not allow a participant to follow study procedures
* Medically unstable due to severe comorbidities, including any condition that a physician deems inappropriate for completing study participation
* Skin problems in areas that would be in contact with the device
* Height, width, weight, or other anatomical limitations (such as differences in leg length) incompatible with the device
* Insufficient joint range of motion (ROM) for the device
* Known pregnancy

Where it's running

  • Sint Maartenskliniek
    Hengstdal, Ubbergen, Netherlands
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.